PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
15-Oct-2024 aap Implantate AG: Possible cyber attack on aap aap Implantate AG
15-Oct-2024 Avant Brands Announces Results for Q3 2024 AccessWire
15-Oct-2024 Global Sustainability Collective and Women’s Mentoring Programme announced at CPHI Milan CPHI Milan
15-Oct-2024 OneSource, a multimodal global specialty pharma CDMO launches at CPHI Milan OneSource
15-Oct-2024 Clinically-validated computer-guided software to launch in up to 150 GP practices across Greater Manchester to support better adult asthma and COPD care Chiesi UK and Ireland and Health Innovation Manchester
15-Oct-2024 Nipocalimab demonstrates sustained disease control in adolescents living with generalised myasthenia gravis in the Phase 2/3 study Nipocalimab
15-Oct-2024 LILLY AND UK GOVERNMENT ANNOUNCE £279 MILLION STRATEGIC COLLABORATION TO TACKLE SIGNIFICANT POPULATION HEALTH CHALLENGES, INCLUDING OBESITY LILLY AND UK GOVERNMENT
15-Oct-2024 Biotech Capital on the Rise and Outsourcing to Accelerate in 2025 - but Uneven Growth for CDMOs CPHI Milan
15-Oct-2024 Lundbeck to acquire Longboard Pharmaceuticals in a strategic deal, significantly enhancing its neuroscience pipeline Lundbeck
15-Oct-2024 Transgene Provides Update on Phase II Trial of Therapeutic Cancer Vaccine TG4001 in Recurrent or Metastatic HPV16-Positive Cervical and Anogenital Cancers Transgene
15-Oct-2024 Innovative Trials appoints new Finance and Business Services Director to drive business growth Innovative Trials
15-Oct-2024 Global Anti-Adhesion Barrier Gels Market Projected to Reach USD 93.42 Million by 2021, Growing at a Robust CAGR of 8.4% MARKITWIRED
15-Oct-2024 Exonucleases Market Projected to Reach USD 208.1 Million by 2032 at a 2.3% of CAGR MARKITWIRED
15-Oct-2024 Roclanda® (netarsudil 0.02% and latanoprost 0.005%) receives positive recommendation from NICE for patients with primary openangle glaucoma or ocular hypertension Roclanda®
15-Oct-2024 Celltrion presents 2-year post-hoc analysis findings for subcutaneous infliximab (CT-P13 SC), highlighting dose escalation as an option for managing loss of response in inflammatory bowel disease Celltrion
15-Oct-2024 Next Generation Mass Spectrometer Market Set to Reach USD 4,097.1 Million by 2032 at a 7.2% of CAGR MARKITWIRED
15-Oct-2024 Sanofi launches high-dose egg-based quadrivalent influenza vaccine (QIV-HD) in the UK Sanofi
15-Oct-2024 Minimally Invasive Neurosurgery Devices Market Expected to Surpass USD 5,950.1 Million by 2033 at a 6.3% of CAGR MARKITWIRED
15-Oct-2024 Vivan Therapeutics' inks New Five-Year Lease at London biotech hub White City Place Vivan Therapeutics
15-Oct-2024 ISPE Names Eli Lilly Kinsale Limited the 2024 Facility of the Year Awards Overall Winner ISPE